Preclinical Data from Isis, UCSD Shows Antisense Infusion Effective for ALS; Phase I Hinges on Cash

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Preclinical Data from Isis, UCSD Shows Antisense Infusion Effective for ALS; Phase I Hinges on Cash
By Doug Macron
July 27, 2006
RNAi News
Based on the findings, Isis said it remains committed to developing the ALS therapy. However, the company still needs to find financial support to move into clinical trials.
Paid subscription is required to view article.